ArticleMolecular imaging and biology2019

Correction to: a Phase 2 Study of 16α-[18F]-Fluoro-17β-Estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC).

Lanell M Peterson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.